Status:
RECRUITING
Insulin Producing Stem Cell Transplantation Clinical Trial in Type 1 Diabetes
Lead Sponsor:
Ain Shams University
Conditions:
Stem Cells
Type 1 Diabetes
Eligibility:
All Genders
15-18 years
Phase:
PHASE2
PHASE3
Brief Summary
Type 1 Diabetes is a chronic autoimmune disease. It results from autoimmune destruction of pancreatic Beta cells leading to absolute insulin insufficiency. The establishment of pluripotent like human ...
Detailed Description
Differentiation of stem cells from various sources to form insulin-producing cells (IPCS) provides a new and promising strategy to reconstitute pancreatic endocrine function. Studies recently develope...
Eligibility Criteria
Inclusion
- Type 1 diabetes
Exclusion
- patients with other autoimmune diseases
- patients with micro or macro vascular complications
- patients with other chronic diseases
Key Trial Info
Start Date :
April 1 2025
Trial Type :
INTERVENTIONAL
Allocation :
ESTIMATED
End Date :
September 1 2026
Estimated Enrollment :
20 Patients enrolled
Trial Details
Trial ID
NCT06951074
Start Date
April 1 2025
End Date
September 1 2026
Last Update
April 30 2025
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
Children Hospital Eldemerdash
Cairo, Egypt